Clinical observations of therapeutic effect of chlorprothixene (Taractan) in psychoses.

@article{Reznikoff1961ClinicalOO,
  title={Clinical observations of therapeutic effect of chlorprothixene (Taractan) in psychoses.},
  author={Leon Reznikoff},
  journal={The American journal of psychiatry},
  year={1961},
  volume={118},
  pages={
          348-50
        }
}
Sixty psychotic patients have been treated with chlorprothixene for 8 to 32 weeks; most of the patients were chronic schizophrenics. Twenty (40%) schizophrenics improved or achieved a remission to be released for convalescent care; 13 (26%) improved sufficiently to participate in hospital social, occupational and recreational activities and 17 (34%) remained unimproved. The number of non-schizophrenic patients was too small to be statistically signfficant. Frequent blood counts and transaminase… CONTINUE READING